1. Home
  2. LGIH vs AMPH Comparison

LGIH vs AMPH Comparison

Compare LGIH & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LGI Homes Inc.

LGIH

LGI Homes Inc.

HOLD

Current Price

$48.22

Market Cap

1.1B

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$18.72

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGIH
AMPH
Founded
2003
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
971.8M
IPO Year
2013
2005

Fundamental Metrics

Financial Performance
Metric
LGIH
AMPH
Price
$48.22
$18.72
Analyst Decision
Hold
Buy
Analyst Count
5
8
Target Price
$75.90
$28.38
AVG Volume (30 Days)
360.1K
710.6K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
0.14
Revenue
$1,705,504,000.00
$719,887,000.00
Revenue This Year
$2.32
$6.90
Revenue Next Year
$17.94
$4.64
P/E Ratio
$540.56
$137.93
Revenue Growth
N/A
N/A
52 Week Low
$33.55
$16.65
52 Week High
$69.42
$31.26

Technical Indicators

Market Signals
Indicator
LGIH
AMPH
Relative Strength Index (RSI) 56.46 44.87
Support Level $45.69 $16.84
Resistance Level $49.51 $20.08
Average True Range (ATR) 2.37 0.80
MACD 0.38 0.11
Stochastic Oscillator 76.19 73.53

Price Performance

Historical Comparison
LGIH
AMPH

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company's current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under the LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company has seven operating segments: West, Northwest, Central, Midwest, Florida, Southeast, and Mid-Atlantic. The majority of the revenue is generated from the Central division segment.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: